The new guidelines recommend against using either IV opioids or IV acetaminophen to treat migraine pain THURSDAY, Dec. 11, 2025 (HealthDay News) — People hospitalized for a debilitating migraine ...
People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids, new treatment guidelines suggest. Photo by Adobe Stock/HealthDay News People hospitalized ...
Migraines affect nearly one in eight adults in the U.S. A new study shows that FDA-approved oral migraine drug atogepant is effective for relieving difficult-to-treat “medication overuse headaches” ...
What Is Ajovy and Why Does It Matter? Ajovy (fremanezumab) is a medicine approved to help prevent migraines. It is a lab-made monoclonal antibody that blocks a protein called calcitonin gene-related ...
Nerve blocks are now recommended to treat migraine pain in the ER The block halts pain signals from traveling along the occipital nerves at the base of the skull The new guidelines recommend against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results